Endoscopic management of sinonasal hemangiopericytoma

Belachew Tessema, Jean Anderson Eloy, Adam J. Folbe, Amy S. Anstead, Neena M. Mirani, Deya N. Joudy, Jose Ruiz, Roy R Casiano

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objective. Sinonasal hemangiopericytomas (SNHPCs) are rare perivascular tumors with low-grade malignant potential. Traditionally, these tumors have been treated with open approaches such as lateral rhinotomy, Caldwell-Luc, or transfacial approaches. Increased experience with endoscopic management of benign and malignant sinonasal tumors has led to a shift in management of SNHPC. The authors present their experience in the largest series of patients with SNHPC managed endoscopically. Study Design and Setting. Case series at a tertiary care medical center. Subjects and Method. A retrospective chart review of all patients undergoing endoscopic management of SNHPC at the University of Miami between 1999 and 2008 was conducted. All endoscopic resections were performed with curative intent. Results. Twelve patients with the diagnosis of SNHPC were treated endoscopically. Mean age was 62.5 years (range, 51-83 years). There were 6 men and 6 women. The mean follow-up was 41 months (range, 15-91 months). Seven (58.3%) presented with nasal obstruction, whereas 4 (41.6%) had epistaxis as their initial presenting symptom. Preoperative angiography or embolization was not performed in any case. Mean estimated blood loss was 630 mL (range, 100-1500 mL). Six patients underwent endonasal endoscopic anterior skull base resection; 4 had complete endoscopic resection all with negative margins. None underwent postoperative adjuvant treatment. No recurrence or metastatic disease was observed in this patient population. Conclusion. Endoscopic management of SNHPC is a feasible approach and did not compromise outcomes in this experience. In this series, familiarity with advance endoscopic sinus surgery was necessary to manage these patients. Postoperative adjuvant therapy was not necessary in this cohort.

Original languageEnglish
Pages (from-to)483-486
Number of pages4
JournalOtolaryngology - Head and Neck Surgery
Volume146
Issue number3
DOIs
StatePublished - Mar 1 2012

Fingerprint

Hemangiopericytoma
Neoplasms
Nasal Obstruction
Epistaxis
Skull Base
Tertiary Care Centers
Angiography
Recurrence
Therapeutics
Population

Keywords

  • Endoscopic
  • Epistaxis
  • Hemangiopericytoma
  • Malignant sinonasal tumors
  • Sinonasal hemangiopericytoma
  • Sinonasal tumors

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Tessema, B., Eloy, J. A., Folbe, A. J., Anstead, A. S., Mirani, N. M., Joudy, D. N., ... Casiano, R. R. (2012). Endoscopic management of sinonasal hemangiopericytoma. Otolaryngology - Head and Neck Surgery, 146(3), 483-486. https://doi.org/10.1177/0194599811427660

Endoscopic management of sinonasal hemangiopericytoma. / Tessema, Belachew; Eloy, Jean Anderson; Folbe, Adam J.; Anstead, Amy S.; Mirani, Neena M.; Joudy, Deya N.; Ruiz, Jose; Casiano, Roy R.

In: Otolaryngology - Head and Neck Surgery, Vol. 146, No. 3, 01.03.2012, p. 483-486.

Research output: Contribution to journalArticle

Tessema, B, Eloy, JA, Folbe, AJ, Anstead, AS, Mirani, NM, Joudy, DN, Ruiz, J & Casiano, RR 2012, 'Endoscopic management of sinonasal hemangiopericytoma', Otolaryngology - Head and Neck Surgery, vol. 146, no. 3, pp. 483-486. https://doi.org/10.1177/0194599811427660
Tessema B, Eloy JA, Folbe AJ, Anstead AS, Mirani NM, Joudy DN et al. Endoscopic management of sinonasal hemangiopericytoma. Otolaryngology - Head and Neck Surgery. 2012 Mar 1;146(3):483-486. https://doi.org/10.1177/0194599811427660
Tessema, Belachew ; Eloy, Jean Anderson ; Folbe, Adam J. ; Anstead, Amy S. ; Mirani, Neena M. ; Joudy, Deya N. ; Ruiz, Jose ; Casiano, Roy R. / Endoscopic management of sinonasal hemangiopericytoma. In: Otolaryngology - Head and Neck Surgery. 2012 ; Vol. 146, No. 3. pp. 483-486.
@article{5457a57bcda34eeda20a0da5a5e99c5e,
title = "Endoscopic management of sinonasal hemangiopericytoma",
abstract = "Objective. Sinonasal hemangiopericytomas (SNHPCs) are rare perivascular tumors with low-grade malignant potential. Traditionally, these tumors have been treated with open approaches such as lateral rhinotomy, Caldwell-Luc, or transfacial approaches. Increased experience with endoscopic management of benign and malignant sinonasal tumors has led to a shift in management of SNHPC. The authors present their experience in the largest series of patients with SNHPC managed endoscopically. Study Design and Setting. Case series at a tertiary care medical center. Subjects and Method. A retrospective chart review of all patients undergoing endoscopic management of SNHPC at the University of Miami between 1999 and 2008 was conducted. All endoscopic resections were performed with curative intent. Results. Twelve patients with the diagnosis of SNHPC were treated endoscopically. Mean age was 62.5 years (range, 51-83 years). There were 6 men and 6 women. The mean follow-up was 41 months (range, 15-91 months). Seven (58.3{\%}) presented with nasal obstruction, whereas 4 (41.6{\%}) had epistaxis as their initial presenting symptom. Preoperative angiography or embolization was not performed in any case. Mean estimated blood loss was 630 mL (range, 100-1500 mL). Six patients underwent endonasal endoscopic anterior skull base resection; 4 had complete endoscopic resection all with negative margins. None underwent postoperative adjuvant treatment. No recurrence or metastatic disease was observed in this patient population. Conclusion. Endoscopic management of SNHPC is a feasible approach and did not compromise outcomes in this experience. In this series, familiarity with advance endoscopic sinus surgery was necessary to manage these patients. Postoperative adjuvant therapy was not necessary in this cohort.",
keywords = "Endoscopic, Epistaxis, Hemangiopericytoma, Malignant sinonasal tumors, Sinonasal hemangiopericytoma, Sinonasal tumors",
author = "Belachew Tessema and Eloy, {Jean Anderson} and Folbe, {Adam J.} and Anstead, {Amy S.} and Mirani, {Neena M.} and Joudy, {Deya N.} and Jose Ruiz and Casiano, {Roy R}",
year = "2012",
month = "3",
day = "1",
doi = "10.1177/0194599811427660",
language = "English",
volume = "146",
pages = "483--486",
journal = "Otolaryngology - Head and Neck Surgery (United States)",
issn = "0194-5998",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Endoscopic management of sinonasal hemangiopericytoma

AU - Tessema, Belachew

AU - Eloy, Jean Anderson

AU - Folbe, Adam J.

AU - Anstead, Amy S.

AU - Mirani, Neena M.

AU - Joudy, Deya N.

AU - Ruiz, Jose

AU - Casiano, Roy R

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Objective. Sinonasal hemangiopericytomas (SNHPCs) are rare perivascular tumors with low-grade malignant potential. Traditionally, these tumors have been treated with open approaches such as lateral rhinotomy, Caldwell-Luc, or transfacial approaches. Increased experience with endoscopic management of benign and malignant sinonasal tumors has led to a shift in management of SNHPC. The authors present their experience in the largest series of patients with SNHPC managed endoscopically. Study Design and Setting. Case series at a tertiary care medical center. Subjects and Method. A retrospective chart review of all patients undergoing endoscopic management of SNHPC at the University of Miami between 1999 and 2008 was conducted. All endoscopic resections were performed with curative intent. Results. Twelve patients with the diagnosis of SNHPC were treated endoscopically. Mean age was 62.5 years (range, 51-83 years). There were 6 men and 6 women. The mean follow-up was 41 months (range, 15-91 months). Seven (58.3%) presented with nasal obstruction, whereas 4 (41.6%) had epistaxis as their initial presenting symptom. Preoperative angiography or embolization was not performed in any case. Mean estimated blood loss was 630 mL (range, 100-1500 mL). Six patients underwent endonasal endoscopic anterior skull base resection; 4 had complete endoscopic resection all with negative margins. None underwent postoperative adjuvant treatment. No recurrence or metastatic disease was observed in this patient population. Conclusion. Endoscopic management of SNHPC is a feasible approach and did not compromise outcomes in this experience. In this series, familiarity with advance endoscopic sinus surgery was necessary to manage these patients. Postoperative adjuvant therapy was not necessary in this cohort.

AB - Objective. Sinonasal hemangiopericytomas (SNHPCs) are rare perivascular tumors with low-grade malignant potential. Traditionally, these tumors have been treated with open approaches such as lateral rhinotomy, Caldwell-Luc, or transfacial approaches. Increased experience with endoscopic management of benign and malignant sinonasal tumors has led to a shift in management of SNHPC. The authors present their experience in the largest series of patients with SNHPC managed endoscopically. Study Design and Setting. Case series at a tertiary care medical center. Subjects and Method. A retrospective chart review of all patients undergoing endoscopic management of SNHPC at the University of Miami between 1999 and 2008 was conducted. All endoscopic resections were performed with curative intent. Results. Twelve patients with the diagnosis of SNHPC were treated endoscopically. Mean age was 62.5 years (range, 51-83 years). There were 6 men and 6 women. The mean follow-up was 41 months (range, 15-91 months). Seven (58.3%) presented with nasal obstruction, whereas 4 (41.6%) had epistaxis as their initial presenting symptom. Preoperative angiography or embolization was not performed in any case. Mean estimated blood loss was 630 mL (range, 100-1500 mL). Six patients underwent endonasal endoscopic anterior skull base resection; 4 had complete endoscopic resection all with negative margins. None underwent postoperative adjuvant treatment. No recurrence or metastatic disease was observed in this patient population. Conclusion. Endoscopic management of SNHPC is a feasible approach and did not compromise outcomes in this experience. In this series, familiarity with advance endoscopic sinus surgery was necessary to manage these patients. Postoperative adjuvant therapy was not necessary in this cohort.

KW - Endoscopic

KW - Epistaxis

KW - Hemangiopericytoma

KW - Malignant sinonasal tumors

KW - Sinonasal hemangiopericytoma

KW - Sinonasal tumors

UR - http://www.scopus.com/inward/record.url?scp=84858817514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858817514&partnerID=8YFLogxK

U2 - 10.1177/0194599811427660

DO - 10.1177/0194599811427660

M3 - Article

C2 - 22049019

AN - SCOPUS:84858817514

VL - 146

SP - 483

EP - 486

JO - Otolaryngology - Head and Neck Surgery (United States)

JF - Otolaryngology - Head and Neck Surgery (United States)

SN - 0194-5998

IS - 3

ER -